Stay updated on Nivolumab for Recurrent Meningioma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Recurrent Meningioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Recurrent Meningioma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:27:09.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect the opening of accrual to Cohort 2 of a clinical trial for recurrent meningioma, with a focus on the drug nivolumab. Additionally, the principal investigator's name has been clarified, and the revision number has been updated.
    Difference
    56%
    Check dated 2025-04-16T20:37:23.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4 and removed a date reference of March 25, 2025, while adding a new date of December 19, 2024.
    Difference
    0.4%
    Check dated 2025-04-09T14:49:42.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous estimated update date of December 19, 2024, and revision version 2.14.2.
    Difference
    0.2%
    Check dated 2025-04-02T00:20:42.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.9%
    Check dated 2025-02-24T23:16:02.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.9%
    Check dated 2025-02-10T16:54:31.000Z thumbnail image

Stay in the know with updates to Nivolumab for Recurrent Meningioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent Meningioma Clinical Trial page.